Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
26 Julho 2023 - 5:05PM
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it
will report second quarter financial results and provide a
corporate update on August 2, 2023. The company will also host a
conference call that day at 5:00 p.m. Eastern Time (2:00 p.m.
Pacific Time).
Conference Call Information
Participants must register in advance of the
conference call by clicking here. Upon registering, each
participant will receive a dial-in number, and a unique access PIN.
Each access PIN will accommodate one caller.
Additionally, a listen-only webcast will be
available by clicking here.
A replay of the call will be available on the
Investors / Events tab of www.corcept.com.
About Corcept Therapeutics
Corcept has discovered a large portfolio of
proprietary compounds that selectively modulate the effects of
cortisol and owns extensive United States and foreign intellectual
property covering both their composition and their use to treat a
variety of serious disorders. Clinical trials are being conducted
with the company’s leading selective cortisol modulators as
potential treatments for patients with serious disorders –
Cushing’s syndrome, ovarian, prostate and adrenal cancer, ALS,
post-traumatic stress disorder and liver disease. Corcept’s drug
Korlym® was the first medication approved by the U.S. Food and Drug
Administration for the treatment of patients with Cushing’s
syndrome.
CONTACT:Corcept TherapeuticsFor
Investor inquiries:ir@corcept.comFor Media
inquiries:CorceptCommunications@corcept.com www.corcept.com
Corcept Therapeutics (NASDAQ:CORT)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Corcept Therapeutics (NASDAQ:CORT)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024